In 2005, the world finally awoke to the possibility of a global influenza pandemic as the avian flu virus spread across Asia into Africa and Europe. But avian flu was hardly the only health concern in the headlines: the continuing diabetes epidemic, the growing threat of nuclear terrorism, and additional warnings on common pain relievers also dominated.
Enter Quigley Pharma. With a growing pipeline, the Company is developing numerous compounds to address several major health issues facing the world today.
+ More
![[Qlogo.gif]](http://www.quigleypharma.com/uploads/images/Qlogo.gif "[Qlogo.gif]")
![[rANDd_module_callout.jpg]](http://www.quigleypharma.com/uploads/images/rANDd_module_callout.jpg "[rANDd_module_callout.jpg]")
![[home_module_foot.gif]](http://www.quigleypharma.com/uploads/images/home_module_foot.gif "[home_module_foot.gif]"){kind=small}